BiondVax Pharmaceuticals Ltd.
Index- P/E- EPS (ttm)-0.82 Insider Own22.88% Shs Outstand18.68M Perf Week-13.87%
Market Cap16.60M Forward P/E- EPS next Y-0.02 Insider Trans0.00% Shs Float14.40M Perf Month-26.87%
Income-11.80M PEG- EPS next Q-0.01 Inst Own1.80% Short Float0.21% Perf Quarter-29.06%
Sales- P/S- EPS this Y-604.60% Inst Trans1.12% Short Ratio0.58 Perf Half Y-54.64%
Book/sh0.33 P/B2.52 EPS next Y-9.80% ROA-45.30% Target Price9.50 Perf Year-62.44%
Cash/sh0.70 P/C1.19 EPS next 5Y- ROE-299.30% 52W Range0.80 - 3.49 Perf YTD-64.68%
Dividend- P/FCF- EPS past 5Y-0.80% ROI- 52W High-76.22% Beta2.31
Dividend %- Quick Ratio5.80 Sales past 5Y- Gross Margin- 52W Low3.75% ATR0.09
Employees15 Current Ratio5.80 Sales Q/Q- Oper. Margin- RSI (14)27.07 Volatility17.39% 9.46%
OptionableNo Debt/Eq4.46 EPS Q/Q-7.10% Profit Margin- Rel Volume1.19 Prev Close0.85
ShortableYes LT Debt/Eq4.41 EarningsAug 25 BMO Payout- Avg Volume52.82K Price0.83
Recom- SMA20-18.38% SMA50-26.38% SMA200-39.63% Volume62,701 Change-2.03%
Sep-22-22 09:05AM
Sep-20-22 06:15AM
Sep-08-22 09:13AM
Aug-25-22 07:30AM
Aug-10-22 08:33AM
10:22AM Loading…
Jun-27-22 10:22AM
Jun-07-22 08:41AM
Jun-01-22 07:10AM
May-19-22 11:17AM
May-12-22 06:30AM
May-09-22 06:00AM
May-02-22 10:15AM
Apr-05-22 06:49AM
Mar-31-22 04:00PM
Mar-28-22 07:00AM
09:45AM Loading…
Mar-24-22 09:45AM
Mar-14-22 08:31AM
Feb-22-22 08:44AM
Feb-15-22 08:31AM
Feb-10-22 04:30AM
Jan-26-22 07:39AM
Jan-10-22 07:00AM
Jan-03-22 10:15AM
Dec-29-21 04:01PM
Dec-27-21 04:01PM
Dec-23-21 08:01PM
Dec-22-21 11:29AM
09:00AM Loading…
Nov-30-21 07:05AM
Nov-24-21 01:46PM
Nov-15-21 05:15AM
Oct-19-21 07:30AM
Sep-15-21 08:59AM
Aug-26-21 04:05PM
Jun-23-21 06:00AM
Jun-15-21 03:23PM
May-13-21 04:54PM
Mar-23-21 07:44AM
Feb-10-21 04:30PM
Feb-03-21 02:45PM
Feb-02-21 04:30PM
Jan-29-21 07:57AM
Jan-28-21 06:48PM
Jan-21-21 07:15AM
Oct-23-20 05:03PM
Oct-02-20 06:00AM
Aug-31-20 06:15AM
Aug-20-20 04:01PM
Aug-13-20 04:01PM
Jul-01-20 06:00AM
Jun-30-20 04:01PM
Jun-16-20 08:57AM
Jun-12-20 08:00AM
Jun-10-20 07:00AM
May-20-20 06:30AM
May-09-20 08:47AM
May-04-20 06:30AM
Mar-24-20 04:01PM
Mar-19-20 07:15AM
Feb-05-20 01:00PM
Jan-16-20 03:05PM
Dec-04-19 08:25AM
Nov-26-19 07:00AM
Nov-18-19 07:15AM
Nov-11-19 08:14AM
Oct-07-19 09:15AM
Aug-28-19 07:45AM
Aug-01-19 10:00AM
Jul-16-19 07:30AM
Jul-08-19 05:45AM
Jun-26-19 10:51AM
Jun-25-19 09:37AM
Jun-18-19 06:30AM
Jun-12-19 03:30PM
Jun-10-19 08:18AM
May-30-19 07:10AM
May-13-19 07:00AM
Apr-30-19 04:01PM
Apr-22-19 08:10AM
Apr-17-19 01:00PM
Apr-15-19 07:50AM
Mar-28-19 07:30AM
Mar-21-19 07:00AM
Nov-28-18 07:40AM
Nov-26-18 07:00AM
Nov-20-18 11:00AM
Nov-19-18 07:00AM
Nov-13-18 04:01PM
Oct-24-18 07:00AM
Oct-22-18 08:00AM
Oct-17-18 08:15AM
Sep-05-18 09:30AM
Sep-04-18 06:15AM
Aug-22-18 07:00AM
BiondVax Pharmaceuticals Ltd., a development stage biopharmaceutical company, focuses on developing, manufacturing, and commercializing products for the prevention and treatment of infectious diseases and other illnesses in Israel. The company has licensing and collaboration agreement with Max Planck Society and University Medical Center Gottingen for the development and commercialization of COVID-19 nanosized antibody (NanoAb); and development and commercialization of NanoAbs for various other disease indications. The company was incorporated in 2003 and is headquartered in Jerusalem, Israel.